|
gptkbp:instanceOf
|
inhaler
|
|
gptkbp:activeDuring
|
budesonide
formoterol
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availableIn
|
various strengths
|
|
gptkbp:clinicalTrials
|
ASTRO study
BLAZE study
SABINA study
SCOOP study
SYGMA study
|
|
gptkbp:contains
|
budesonide
formoterol
|
|
gptkbp:contraindication
|
severe asthma attacks
hypersensitivity to ingredients
|
|
gptkbp:dosageForm
|
dry powder inhaler
|
|
gptkbp:drugInterdiction
|
true
|
|
gptkbp:formulation
|
metered-dose
|
|
gptkbp:hasCapacity
|
adults
children over 12 years
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Symbicort Turbuhaler
|
|
gptkbp:impact
|
as needed
long-term
|
|
gptkbp:issuedBy
|
inhalation
|
|
gptkbp:lastProduced
|
2006
|
|
gptkbp:mandates
|
maintenance treatment
relief of symptoms
|
|
gptkbp:manufacturer
|
gptkb:AstraZeneca
|
|
gptkbp:offersCoursesIn
|
gptkb:Australia
gptkb:Brazil
gptkb:Canada
gptkb:France
gptkb:Germany
gptkb:India
gptkb:Japan
gptkb:South_Africa
gptkb:UK
gptkb:USA
|
|
gptkbp:packaging
|
plastic inhaler
|
|
gptkbp:shelfLife
|
3 years
|
|
gptkbp:sideEffect
|
headache
nausea
cough
palpitations
thrush
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:triggerType
|
anti-inflammatory
bronchodilator
|
|
gptkbp:usedFor
|
asthma
chronic obstructive pulmonary disease (COPD)
|